Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma - Konstantinopoulos, P A; Waggoner, S; Vidal, G A (JAMA Oncol, 2019)